ArticlePloS one2022
Survival analysis of cancer patients using a new extended Weibull distribution.
Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- A stochastic modelling framework for cancer patient trajectories: combining tumour growth, metastasis, and survival.Journal of mathematical biology · 2025Article
- Article
- The development of an extended Weibull model with applications to medicine, industry and actuarial sciences.Scientific reports · 2024Article
- A new family of distributions using a trigonometric function: Properties and applications in the healthcare sector.Heliyon · 2024Article
- Prioritizing Disease Diagnosis in Neonatal Cohorts through Multivariate Survival Analysis: A Nonparametric Bayesian Approach.Healthcare (Basel, Switzerland) · 2024Article
- A new flexible Weibull extension model: Different estimation methods and modeling an extreme value data.Heliyon · 2023Article
- Applicability of modified weibull extension distribution in modeling censored medical datasets: a bayesian perspective.Scientific reports · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
One of the most important applications of statistical analysis is in health research and applications. Cancer studies are mostly required special statistical considerations in order to find the appropriate model for fitting the survival data. Existing classical distributions rarely fit such data well and an increasing interest has been shown recently in developing more flexible distributions by introducing some additional parameters to the basic model. In this paper, a new five-parameters distribution referred as alpha power Kumaraswamy Weibull distribution is introduced and studied. Particularly, this distribution extends the Weibull distribution based on a novel technique that combines two well known generalisation methods, namely, alpha power and T-X transformations. Different characteristics of the proposed distribution, including moments, quantiles, Rényi entropy and order statistics are obtained. The method of maximum likelihood is applied in order to estimate the model parameters based on complete and censored data. The performance of these estimators are examined via conducting some simulation studies. The potential importance and applicability of the proposed distribution is illustrated empirically by means of six datasets that describe the survival of some cancer patients. The results of the analysis indicated to the promising performance of the alpha power Kumaraswamy Weibull distribution in practice comparing to some other competing distributions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.